Ashland Q3 Earnings and Sales Lag Estimates, Guidance Narrowed
Werte in diesem Artikel
Ashland Global Holdings Inc. ASH recorded a loss of $742 million or $16.21 per share in third-quarter fiscal 2025 (ended June 30) compared with a profit of $6 million or 12 cents in the prior-year quarter.Barring one-time items, adjusted earnings were $1.04 per share, down from the year-ago quarter’s figure of $1.49. The bottom line missed the Zacks Consensus Estimate of $1.15.Sales were down 14.9% year over year to $463 million. The top line missed the Zacks Consensus Estimate of $468.4 million. Sales for the fiscal third quarter were adversely impacted by the portfolio optimization actions involving curtailing or divesting certain lower-margin products, lower volumes in Specialty Additives and Personal Care, and reduced pricing in Life Sciences and Intermediates.Ashland Inc. Price, Consensus and EPS Surprise Ashland Inc. price-consensus-eps-surprise-chart | Ashland Inc. QuoteASH’s Segment HighlightsLife Sciences:Sales in the segment were down 17% year over year to $162 million in the reported quarter. The Zacks Consensus Estimate for the same was $170 million. The decline was primarily caused by the divestiture of the Neutraceuticals division and the exit of the low-margin nutrition offerings.Personal Care:Sales in the division declined 16% year over year to $147 million. The metric met the Zacks Consensus Estimate. The decrease was mostly due to portfolio optimization, mainly attributed to the divestiture of the Avoca business line.Specialty Additives:Sales in the segment fell 13% year over year to $131 million but beat the Zacks Consensus Estimate of $124 million. The decline was mostly due to the exit from the low-margin construction business to optimize the portfolio.Intermediates: Sales in the segment went down 8% year over year to $33 million. The figure also missed the consensus estimate of $34.8 million. The overall sales decreased, mostly due to lower prices.ASH’s FinancialsCash and cash equivalents were $207 million at the end of the quarter, up around 23.2% sequentially. Long-term debt was $1,382 million, up roughly 3.4% over the same time frame.ASH’s OutlookFor the full fiscal year, Ashland now expects sales to be in the range of $1.825-$1.85 billion and adjusted EBITDA to be $400-$410 million, narrowing from the previous estimate of $1.825-$1.9 billion and $400-$420 million, respectively.ASH’s Price PerformanceShares of Ashland have lost 42.5% in the past year compared with a 1.3% decline in the industry.Image Source: Zacks Investment ResearchASH’s Zacks Rank & Key PicksASH currently carries a Zacks Rank #5 (Strong Sell).Better-ranked stocks worth a look in the basic materials space include Royal Gold, Inc. RGLD, Lithium Americas Corp. LAC and MAG SilverCorp. MAG.Royal Gold is slated to report second-quarter results on Aug. 6. The Zacks Consensus Estimate for earnings is pegged at $1.70 per share. RGLD’s earnings beat the Zacks Consensus Estimate in each of the last four quarters, with the average surprise being 9%. Royal Gold flaunts a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.Lithium Americas is expected to report second-quarter results on Aug. 12. The Zacks Consensus Estimate for LAC’s second-quarter earnings is pegged at a loss of 4 cents per share, indicating year-over-year growth of 20%. Lithium Americas’ earnings beat the Zacks Consensus Estimate in one of the last four quarters but missed it in the rest. LAC currently carries a Zacks Rank #2 (Buy).MAG Silver is slated to report second-quarter results on Aug. 11. The consensus estimate for MAG’s earnings is pegged at 26 cents per share. MAG carries a Zacks Rank #2 at present. MAG Silver’s earnings beat the consensus estimate in three of the last four quarters, while missing it in one, with the average surprise being 2.01%. Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent. Thousands have taken advantage of this opportunity.Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators, and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ashland Inc. (ASH): Free Stock Analysis Report Royal Gold, Inc. (RGLD): Free Stock Analysis Report MAG Silver Corporation (MAG): Free Stock Analysis Report Lithium Americas Corp. (LAC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Ashland Global und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Ashland Global
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Ashland Global
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Ashland Global Holdings Inc
Analysen zu Ashland Global Holdings Inc
Datum | Rating | Analyst | |
---|---|---|---|
29.03.2018 | Ashland Global Outperform | BMO Capital Markets | |
31.01.2018 | Ashland Global Neutral | Monness, Crespi, Hardt & Co. | |
16.05.2017 | Ashland Global Buy | Monness, Crespi, Hardt & Co. | |
28.11.2016 | Ashland Buy | Deutsche Bank AG | |
27.01.2016 | Ashland Buy | Monness, Crespi, Hardt & Co. |
Datum | Rating | Analyst | |
---|---|---|---|
29.03.2018 | Ashland Global Outperform | BMO Capital Markets | |
16.05.2017 | Ashland Global Buy | Monness, Crespi, Hardt & Co. | |
28.11.2016 | Ashland Buy | Deutsche Bank AG | |
27.01.2016 | Ashland Buy | Monness, Crespi, Hardt & Co. | |
23.09.2015 | Ashland Buy | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
31.01.2018 | Ashland Global Neutral | Monness, Crespi, Hardt & Co. | |
04.01.2007 | Update Ashland Inc.: Hold | Matrix Research | |
03.01.2007 | Update Ashland Inc.: Hold | KeyBanc Capital Markets / McDonald | |
05.12.2006 | Update Ashland Inc.: Neutral | JP Morgan | |
15.11.2006 | Update Ashland Inc.: Neutral | Credit Suisse |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ashland Global Holdings Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen